Skip to main content
Clinical Trials/NCT07307079
NCT07307079
Completed
Not Applicable

Effectiveness of Non-Invasive High-Frequency Oscillatory Ventilation vs Conventional Ventilation for Preterm Neonates With Respiratory Distress Syndrome Following Nasal CPAP Failure.

Muhammad Aamir Latif1 site in 1 country100 target enrollmentStarted: June 1, 2025Last updated:

Overview

Phase
Not Applicable
Status
Completed
Sponsor
Muhammad Aamir Latif
Enrollment
100
Locations
1
Primary Endpoint
Improvement in ventilation parameter

Overview

Brief Summary

Given the high burden of respiratory distress syndrome (RDS) and its complications in resource-constrained settings, identifying effective, low-risk interventions is imperative. The study aimed to assess the improvement in oxygenation and ventilation parameters initiating non-invasive high-frequency oscillatory ventilation (nHFOV) or conventional mechanical ventilation (CMV) and to compare the incidence of air leaks, sepsis, bronchopulmonary dysplasia (BPD), intraventricular hemorrhage (IVH), prolonged hospital stays, and short-term survival rates.

Detailed Description

Global neonatal care is moving toward lung-protective ventilation strategies to improve outcomes for preterm neonates. Evaluating the role of nHFOV in low- and middle-income countries (LMICs) like Pakistan not only helps address local healthcare challenges but also contributes to global efforts to optimize neonatal care across diverse settings. To best of my knowledge no such type of study has been conducted in Pakistan. This study is non-invasive and cost effective. The findings of this study could inform policy decisions and resource allocation in NICUs across Pakistan and other middle-income countries (LMICs).

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
1 Day to 28 Days (Child)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Neonates of any gender
  • Gestational age between 26 and 36 weeks
  • Diagnosed with RDS.
  • Failed to respond to nCPAP treatment

Exclusion Criteria

  • Major congenital anomalies like congenital diaphragmatic hernia, dysmorphism and congenital heart diseases
  • Early onset sepsis at the time of enrollment

Outcomes

Primary Outcomes

Improvement in ventilation parameter

Time Frame: 24 hours

Improvement in ventilation parameter, measured by arterial blood gas analysis of the assigned ventilation modality was noted.

Secondary Outcomes

  • Bronchopulmonary dysplasia(36 weeks post-menstrual age)
  • Sepsis(28 days)
  • Ventilator-Associated Pneumonia(48 hours)
  • Duration of respiratory support(28 days)
  • Survival Status at Discharge(28 days)

Investigators

Sponsor
Muhammad Aamir Latif
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

Muhammad Aamir Latif

Research Consultant

RESnTEC, Institute of Research

Study Sites (1)

Loading locations...

Similar Trials